Melatonin as a potential therapeutic agent in psychiatric illness. (Q34018192)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19551767 AND SRC:MED&resulttype=core&format=json

1 February 2020

review article

1 reference

title

Melatonin as a potential therapeutic agent in psychiatric illness (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19551767 AND SRC:MED&resulttype=core&format=json

1 February 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19551767 AND SRC:MED&resulttype=core&format=json

1 February 2020

2

Russel J Reiter

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19551767 AND SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Maria A Pérez-San-Gregorio

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19551767 AND SRC:MED&resulttype=core&format=json

1 February 2020

publication date

1 July 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19551767 AND SRC:MED&resulttype=core&format=json

1 February 2020

published in

Human Psychopharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19551767 AND SRC:MED&resulttype=core&format=json

1 February 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19551767 AND SRC:MED&resulttype=core&format=json

1 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19551767 AND SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

391-400

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19551767 AND SRC:MED&resulttype=core&format=json

Effect of melatonin administration on sleep, behavioral disorders and hypnotic drug discontinuation in the elderly: a randomized, double-blind, placebo-controlled study

1 February 2020

cites work

1 reference

A randomized, double-blind, placebo-controlled crossover study of the effect of exogenous melatonin on delayed sleep phase syndrome

21 January 2018

1 reference

Melatonin inhibits fatty acid-induced triglyceride accumulation in ROS17/2.8 cells: implications for osteoblast differentiation and osteoporosis.

21 January 2018

1 reference

Possible immunological effects of psychotropic medication

21 January 2018

1 reference

Adult neurogenesis, neuroinflammation and therapeutic potential of adult neural stem cells

21 January 2018

1 reference

Cognitive impairment in later life in patients with early-onset bipolar disorder.

21 January 2018

1 reference

A new guest playing with bone and fat

21 January 2018

1 reference

7 January 2021

Endogenous melatonin provides an effective circadian message to both the suprachiasmatic nuclei and the pars tuberalis of the rat.

1 reference

7 January 2021

Fluoxetine treatment increases trabecular bone formation in mice

1 reference

7 January 2021

Sleep in schizophrenia: impairments, correlates, and treatment

1 reference

7 January 2021

Melatonin add-on in manic patients with treatment resistant insomnia

1 reference

7 January 2021

Melatonin effects on bone: experimental facts and clinical perspectives

1 reference

7 January 2021

Evidence of melatonin synthesis by human lymphocytes and its physiological significance: possible role as intracrine, autocrine, and/or paracrine substance.

1 reference

7 January 2021

Beneficial pleiotropic actions of melatonin in an experimental model of septic shock in mice: regulation of pro-/anti-inflammatory cytokine network, protection against oxidative damage and anti-apoptotic effects

1 reference

7 January 2021

Human lymphocyte-synthesized melatonin is involved in the regulation of the interleukin-2/interleukin-2 receptor system.

1 reference

7 January 2021

Neuroleptic Treatment Effect on Mitochondrial Electron Transport Chain

1 reference

7 January 2021

Effects of antidepressants on cytokine production and actions.

1 reference

7 January 2021

Substance use, affective problems and personality traits: test of two association models

1 reference

7 January 2021

Preclinical evaluation of pharmacokinetics and safety of melatonin in propylene glycol for intravenous administration

1 reference

7 January 2021

Neutrophilia and lymphopenia in major mood disorders.

1 reference

7 January 2021

Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures

1 reference

7 January 2021

Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease

1 reference

7 January 2021

Functional MT1 and MT2 melatonin receptors in mammals

1 reference

7 January 2021

Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians

1 reference

7 January 2021

Newer treatment studies for bipolar depression

1 reference

7 January 2021

Involvement of nuclear binding sites for melatonin in the regulation of IL-2 and IL-6 production by human blood mononuclear cells

1 reference

7 January 2021

Correlation between nuclear melatonin receptor expression and enhanced cytokine production in human lymphocytic and monocytic cell lines

1 reference

7 January 2021

Cellular mechanisms involved in the melatonin inhibition of HT-29 human colon cancer cell proliferation in culture

1 reference

7 January 2021

Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials

1 reference

7 January 2021

Early indicators of chronic lung disease in preterm infants with respiratory distress syndrome and their inhibition by melatonin.

1 reference

7 January 2021

Oxidative and inflammatory parameters in respiratory distress syndrome of preterm newborns: beneficial effects of melatonin

1 reference

7 January 2021

Correlation among cytokines, bronchopulmonary dysplasia and modality of ventilation in preterm newborns: improvement with melatonin treatment.

1 reference

7 January 2021

Stress-induced immune dysregulation: implications for wound healing, infectious disease and cancer

1 reference

7 January 2021

Identification of a serotonin/glutamate receptor complex implicated in psychosis

1 reference

7 January 2021

Involvement of AMPA receptors in the antidepressant-like effects of lithium in the mouse tail suspension test and forced swim test

1 reference

7 January 2021

Chronic administration of melatonin reduces cerebral injury biomarkers in SAMP8.

1 reference

7 January 2021

Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men.

1 reference

7 January 2021

The pattern of melatonin receptor expression in the brain may influence antidepressant treatment

1 reference

7 January 2021

Central CRH system in depression and anxiety--evidence from clinical studies with CRH1 receptor antagonists

1 reference

7 January 2021

Protective effect of melatonin against hippocampal injury of rats with intermittent hypoxia

1 reference

7 January 2021

The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases

1 reference

7 January 2021

Melatonin inhibits iron-induced epileptic discharges in rats by suppressing peroxidation

1 reference

7 January 2021

T-helper types 1, 2, and 3 cytokine interactions in symptomatic manic patients

1 reference

7 January 2021

Depression, cortisol metabolism and lymphocytopenia

1 reference

7 January 2021

Melatonin suppression in bipolar and unipolar mood disorders

1 reference

7 January 2021

Stress and the immune system in the etiology of anxiety and depression

1 reference

7 January 2021

HPA and immune axes in stress: involvement of the serotonergic system

1 reference

7 January 2021

Psychopathology of depression

1 reference

7 January 2021

Inflammation and depression: is there a causal connection with dementia?

1 reference

7 January 2021

Changes in the immune system in rodent models of depression

1 reference

7 January 2021

Neuroprotective effects of melatonin

1 reference

7 January 2021

Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock.

1 reference

7 January 2021

Human pineal physiology and functional significance of melatonin

1 reference

7 January 2021

Interleukin-2 and interleukin-6 in schizophrenia and mania: Effects of neuroleptics and mood stabilizers

1 reference

7 January 2021

Melatonin as pharmacologic support in burn patients: a proposed solution to thermal injury-related lymphocytopenia and oxidative damage.

1 reference

7 January 2021

The potential of melatonin in reducing morbidity-mortality after craniocerebral trauma.

1 reference

7 January 2021

Melatonin Administration Attenuates Depressed Immune Functions after Trauma-Hemorrhage

1 reference

7 January 2021

Should Depressive Syndromes Be Reclassified as "Metabolic Syndrome Type II"?

1 reference

7 January 2021

Bipolar disorder and suicide: research synthesis and clinical translation

1 reference

7 January 2021

Utility of high doses of melatonin as adjunctive anticonvulsant therapy in a child with severe myoclonic epilepsy: two years' experience

1 reference

7 January 2021

Seasonality of psychopathology and circannual melatonin rhythm

1 reference

7 January 2021

Melatonin influences the proliferative and differentiative activity of neural stem cells

1 reference

7 January 2021

The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view.

1 reference

7 January 2021

Th1, Th2, and Th3 cytokine alterations in major depression

1 reference

7 January 2021

Monocytic, Th1 and th2 cytokine alterations in the pathophysiology of schizophrenia

1 reference

7 January 2021

Melatonin suppression by light in euthymic bipolar and unipolar patients.

1 reference

7 January 2021

Towards a unifying hypothesis of neurodegenerative diseases and a concomitant rational strategy for their prophylaxis and therapy.

1 reference

7 January 2021

Obsessive-compulsive disorder: a neuronal membrane phospholipid hypothesis and concomitant therapeutic strategy

1 reference

7 January 2021

Melatonin: Nature's most versatile biological signal?

1 reference

7 January 2021

Melatonin response to clonidine administration in depression: indication of presynaptic alpha2-adrenoceptor dysfunction.

1 reference

7 January 2021

Orally administered melatonin improves nocturnal rest in young and old ringdoves (Streptopelia risoria).

1 reference

7 January 2021

Self-reported sleep disturbance as a prodromal symptom in recurrent depression

1 reference

7 January 2021

Potential role of tryptophan derivatives in stress responses characterized by the generation of reactive oxygen and nitrogen species.

1 reference

7 January 2021

Melatonin is a safe and effective treatment for chronic pulmonary and extrapulmonary sarcoidosis

1 reference

7 January 2021

Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review

1 reference

7 January 2021

Melatonin enhances alkaline phosphatase activity in differentiating human adult mesenchymal stem cells grown in osteogenic medium via MT2 melatonin receptors and the MEK/ERK (1/2) signaling cascade.

1 reference

7 January 2021

Melatonin: clinical relevance

1 reference

7 January 2021

When melatonin gets on your nerves: its beneficial actions in experimental models of stroke

1 reference

7 January 2021

Melatonin as an antioxidant: physiology versus pharmacology.

1 reference

7 January 2021

Melatonin: reducing the toxicity and increasing the efficacy of drugs

1 reference

7 January 2021

Case study: the use of melatonin in a boy with refractory bipolar disorder

1 reference

7 January 2021

Melatonin treatment for tardive dyskinesia: a double-blind, placebo-controlled, crossover study

1 reference

7 January 2021

First-night effect of melatonin treatment in patients with chronic schizophrenia

1 reference

7 January 2021

Shared gene expression alterations in schizophrenia and bipolar disorder

1 reference

7 January 2021

Melatonin as a potential antihypertensive treatment

1 reference

7 January 2021

Chronotherapy beyond blood pressure reduction?

1 reference

7 January 2021

The comparison of changes in behavior, neurochemistry, endocrine, and immune functions after different routes, doses and durations of administrations of IL-1beta in rats

1 reference

7 January 2021

Melatonin in mood disorders

1 reference

7 January 2021

Immunomodulation by melatonin: its significance for seasonally occurring diseases

1 reference

7 January 2021

Pathophysiology of depression: role of sleep and the melatonergic system

1 reference

7 January 2021

Melatonin in schizophrenic outpatients with insomnia: a double-blind, placebo-controlled study

1 reference

7 January 2021

Accelerated apoptosis of blood leukocytes and oxidative stress in blood of patients with major depression

1 reference

7 January 2021

Identification of highly elevated levels of melatonin in bone marrow: its origin and significance

1 reference

7 January 2021

One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species?

1 reference

7 January 2021

The prevalence of metabolic syndrome among psychiatric inpatients in Brazil

1 reference

7 January 2021

Depression, Inflammation, and Incident Cardiovascular Disease in Women With Suspected Coronary Ischemia

1 reference

7 January 2021

Amino acids in schizophrenia: evidence for lower tryptophan availability during treatment with atypical antipsychotics?

1 reference

7 January 2021

Serological observations in patients suffering from acute manic episodes

1 reference

7 January 2021

Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia

1 reference

7 January 2021

Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder

1 reference

7 January 2021

Sleep-facilitating effect of exogenous melatonin in healthy young men and women is circadian-phase dependent

1 reference

7 January 2021

The brain's master circadian clock: implications and opportunities for therapy of sleep disorders

1 reference

7 January 2021

Agomelatine: a preliminary review of a new antidepressant

1 reference

7 January 2021

Identifiers

DOI

10.1002/HUP.1032

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19551767 AND SRC:MED&resulttype=core&format=json

1 February 2020

1 reference